CareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers products, testing services, and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.
We are seeking an experienced and detail-oriented Finance Accountant to join our team in Stockholm. This role requires background in finance or accounting and hands-on experience with NetSuite or similar ERP systems. The successful candidate will be well-organized, proactive, and capable of working in a fast-paced international environment.
This role is based on-site in Stockholm, with a requirement to work from the office at least three days per week
Responsibilities:
- Prepare salary documentation for employees across multiple countries and coordinate with local payroll providers
- Review payroll documentation and process salary payments
- Review and process employee expense reports
- Book vendor invoices and manage approval workflows via Centsoft
- Match purchase orders to invoices
- Prepare payment proposals for accounts payable
- Amortize vendor invoices
- Reconcile accounts and support month-end close
- Book received customer payments and manage collections
- Perform intercompany reconciliations
Italicized tasks are performed as backup during vacation periods.
Requirements:
- Fluent in English and Swedish (required); German or Spanish is a plus
- Strong proficiency in Microsoft Office
- Experience with NetSuite or other integrated ERP systems
- Prior experience in an international company
- Excellent attention to detail and organizational skills
- Ability to work independently and manage multiple priorities
Additional Details:
Every individual at CareDx has a direct impact on our collective mission to improve the lives of organ transplant patients worldwide. We believe in taking great care of our people, so they take even greater care of our patients.
In addition, we have a Living Donor Employee Recovery Policy that allows up to 30 days of paid leave annually to a full-time employee who makes the selfless act of donating an organ or bone marrow.
With products that are making a difference in the lives of transplant patients today and a promising pipeline for the future, it’s an exciting time to be part of the CareDx team. Join us in partnering with transplant patients to transform our future together.
***We do not accept resumes from headhunters, placement agencies, or other suppliers that have not signed a formal agreement with us.***
Certain jurisdictions require notice of how we use and protect your personal information. For more information, please read our Privacy Policy.
Top Skills
What We Do
CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions
CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions.
NASDAQ:CDNA
About AlloSure®
AlloSure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. AlloSure is a clinical-grade, proprietary Next-Generation Sequencing (NGS) based test to detect donor-derived cell-free DNA (dd-cfDNA) in order to identify organ injury in kidney transplant recipients. AlloSure is analytically validated as a sensitive, specific, and precise measurement of dd-cfDNA. AlloSure detects active rejection (acute active ABMR, chronic active ABMR, or TCMR) with high accuracy, outperforms serum creatinine in kidney transplant recipients, and is highly sensitive in distinguishing ABMR from no ABMR. AlloSure is performed in the CareDx CLIA-certified laboratory.
http://www.allosure.com/
About AlloMap®
AlloMap Molecular Expression Testing is a non-invasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. AlloMap testing measures the expression levels of 20 genes from a blood sample. The combined expression of these genes is represented as an AlloMap test score. AlloMap is performed in the CareDx CLIA-certified laboratory and has been commercially available in the United States since 2005. AlloMap was cleared by the U.S. Food and Drug Administration in 2008 and was CE marked for the European Union in 2011. Use of AlloMap is also included in the International Society for Heart and Lung Transplantation (ISHLT) Practice Guidelines, published in August 2010, the worldwide standard for the care of heart transplant patients.
http://www.allomap.com/
